Loader
Latest News
HR7289: Federal PFAS Research Evaluation Act (117th Congress)
20716
wp-singular,page-template-default,page,page-id-20716,wp-theme-bridge,bridge-core-3.3.4.9,qode-optimizer-1.2.3,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode_grid_1400,side_menu_slide_from_right,qode-theme-ver-30.8.9.1,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-9.0.1,vc_responsive
 

HR7289: Federal PFAS Research Evaluation Act

117th Congress (2021–2023) · House bill · Sponsor: Rep. Fletcher, Lizzie [D-TX-7]

This page covers HR7289 in the 117th Congress. Bill numbers start over every Congress, so HR7289 in another Congress is a different bill.


Key facts

Item Detail
Roll-call votes 1
Chamber House
Latest vote 2022-07-26: Passed
Latest action 2022-07-27: Received in the Senate and Read twice and referred to the Committee on Environment and Public Works.
Policy area Environmental Protection
Official record Congress.gov

What the bill does

Federal PFAS Research Evaluation Act This bill requires the Environmental Protection Agency (EPA) to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine (NASEM) to complete various studies and reports related to perfluoroalkyl and polyfluoroalkyl substances, commonly referred to as PFAS. PFAS are man-made and may have adverse human health effects. A variety of products contain the compounds, such as nonstick cookware or weatherproof clothing. Specifically, the bill requires the EPA to enter into an agreement with NASEM to (1) study and report on research and knowledge gaps identified by the Federal Government Human Health PFAS Research Workshop (October 26 and 27, 2020); and (2) identify research and development needed to identify, categorize, evaluate, and address individual or total PFAS. Additionally, the EPA and other relevant federal agencies must enter into an agreement with NASEM to submit a study and report to better understand the research and development needed to better understand the extent and implications of human and environmental contamination by PFAS and any management and treatment options. After NASEM submits the required reports, the White House Office of Science and Technology Policy must submit an implementation plan to Congress for increased collaboration and coordination of federal PFAS research, development, and demonstration activities.

Subjects: Animal and plant health, Congressional oversight, Environmental assessment, monitoring, research, Environmental health, Government information and archives, Government studies and investigations, Hazardous wastes and toxic substances, Product safety and quality, Research administration and funding, Research and development


Roll-call votes on HR7289 (117th Congress)

Every recorded vote on this bill, newest first, with a link to the official tally. Member-by-member positions are on each member’s profile.

Date Chamber Question Result Yea Nay Not voting Record
2022-07-26 House 2/3 Yea-And-Nay Passed 244 49 3 Official tally

Frequently asked

What is HR7289 in the 117th Congress?

HR7289 (Federal PFAS Research Evaluation Act) was introduced in the 117th Congress (2021–2023) by Rep. Fletcher, Lizzie [D-TX-7].

What is the latest action on HR7289?

On 2022-07-27: Received in the Senate and Read twice and referred to the Committee on Environment and Public Works.

How many roll-call votes were held on HR7289?

1 recorded vote in the 117th Congress. The most recent, on 2022-07-26, was "2/3 Yea-And-Nay": Passed.